Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation

British Journal of Pharmacology

Volumn 126, Issue 2, 1999, Pages 457-466

  Niederhoffer, Nathalie ^a   Szabo, Bela ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Baroreflex; Blood pressure; Cannabinoid receptor; Cardiovascular regulation; Conscious rabbit; Heart rate; Pithed rabbit; Plasma noradrenaline; Presynaptic receptor; Sympathetic nerve activity

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; NORADRENALIN; RIMONABANT;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CISTERNA MAGNA; ELECTROSTIMULATION; FEMALE; HYPOTENSION; INTRACISTERNAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE STIMULATION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RABBIT; SPINAL ANIMAL; TACHYCARDIA;

ANALGESICS; ANIMALS; BLOOD PRESSURE; BRADYCARDIA; CANNABINOIDS; CARDIOVASCULAR PHYSIOLOGY; CISTERNA MAGNA; CONSCIOUSNESS; CYCLOHEXANOLS; DECEREBRATE STATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; HEART RATE; INFUSIONS, INTRAVENOUS; INJECTIONS; INJECTIONS, INTRAVENOUS; KIDNEY; MALE; MORPHOLINES; NAPHTHALENES; NOREPINEPHRINE; PIPERIDINES; PYRAZOLES; RABBITS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STEREOISOMERISM; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS;

EID: 0032929957     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702337     Document Type: Article

References (46)

1. 9-tetrahydrocannabinol in the rat. Br. J. Pharmacol., 56, 43-48.
2. Benowitz, N.L. & Jones, R.T. (1975). Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin. Pharmacol. Ther., 18, 287-297.
3. Benowitz, N.L , Rosenberg, J., Rogers, W., Bachman, J. & Jones, R.T. (1979). Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: Autonomic nervous mechanisms. Clin. Pharmacol. Ther., 25, 440-446.
4. 9-tetrahydrocannabino\ in the blood pressure of hypertensive rats bearing regenerated adrenal glands. Br. J. Pharmacol., 48, 169-171.
5. 9-trans-tetrahydrocannabinol on myocardial contractility and venous return in anesthetized dogs. Eur. J. Pharmacol., 29, 74-82.
6. 9-trans-tetrahydrocannabinol in anesthetized dogs. Eur. J. Pharmacol., 22, 263-269.
7. 9-trans-tetrahydrocannabinol in anesthetized dogs. Res. Comm. Chem. Pathol. Pharmacol., 6, 527-540.
8. Compton, D.R., Harris, L.S., Lichtman, A.H. & Martin, B.R. (1996). Marihuana. In Pharmacological Aspects of Drug Dependence. Handbook of Experimental Pharmacology. eds. Schuster, C.R. & Kuhar, M.J. pp. 83-158. Springer: Heidelberg.
9. Dewey, W.L. (1986). Cannabinoid pharmacology. Pharmacol. Rev., 38, 151-178.
10. Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M. & Eisenhofer, G. (1990). Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev., 70, 963-985.
11. 9(11)-tetrahydrocannabinol and their interaction with epinephrine. Life Sci., 41, 79-87.
12. 2 receptors. Molec. Pharmacol., 48, 443-450.
13. Fredericks, A.B., Benowitz, N.L. & Savanapridi, C.Y. (1981). The cardiovascular and autonomic effects of repeated administration of Δ-9-tetrahydrocannabinol to rhesus monkeys. J. Pharmacol. Exp. Ther., 216, 247-253.
14. Graham, J.D.P. & Li, D.M.F. (1973). Cardiovascular and respiratory effects of cannabis in cat and rat. Br. J. Pharmacol., 49, 1-10.
15. 2-like cannabinoid receptors on peripheral nerve terminals. Eur. J. Pharmacol., 339, 53-61.
16. Howlett, A.C. (1995). Pharmacology of cannabinoid receptors. Ann. Rev. Pharmacol. Toxicol., 35, 607-634.
17. Huestis, M.A., Sampson, A.H., Holicky, B.J., Henningfield, J.E. & Cone, E.J. (1992). Characterization of the absorption phase of marijuana smoking. Clin. Pharmacol. Ther., 52, 31-41.
18. 1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol., 118, 2023-2028.
19. 9-tetrahydrocannabinol in conscious and morphine-chloralose-anesthetized dogs: anesthetic influence on drug action. Eur. J. Pharmacol., 53, 63-68.
20. 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats. Eur. J. Pharmacol., 65, 63-69.
21. Kuster, J.E., Stevenson, J.I., Ward, S.J., D'Ambra, T.E. & Haycock, D.A. (1993). Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J. Pharmacol. Exp. Ther., 264, 1352-1363.
22. 1-like cannabinoid receptors. J. Pharmacol. Exp. Ther., 281, 1030-1037.
23. Lake, K.D., Martin, B.R., Kunos, G. & varga, K. (1997b). Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension, 29, 1204-1210.
24. Mailleux, P. & Vanderhaeghen, J.J. (1992). Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience, 48, 655-668.
25. 1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. NaunynSchmiedeberg's Arch. Pharmacol., 356, 197-202.
26. Martin, B.R. (1986). Cellular effects of cannabinoids. Pharmacol. Rev., 38, 45-74.
27. Matsuda, L.A., Lolait, S.J., Brownstein, B.J., Young, A.C. & Bonner, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
28. Munro, S., Thomas, K.L. & Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
29. 9-tetrahydrocannabinol and dimethyl-heptylpyran induced tachycardia in the conscious rat. Life Sci., 21, 1329-1336.
30. 2 receptors. Pharmacol. Ther., 74, 129-180.
31. Pertwee, R.G., Stevenson, L.A., Elrick, D.B., Mechoulam, R. & Corbett, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980-984.
32. Randall, M.D., Alexander, S.P.H., Bennett, T., Boyd, E.A., Fry, J.R., Gardiner, S.M., Kemp, P.A., Mcculloch, A.I. & Kendall, D.A. (1996). An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Comm., 229, 114-120.
33. Randall, M.D. & Kendall, D. A. (1997). Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur. J. Pharmacol., 335, 205-209.
34. Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara, P., Soubrie, P., Breliere, J.C. & Le Fur, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
35. Showalter, V.M., Compton, D.R., Martin, B.R. & Abood, M.A. (1996). Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 278, 989-999.
36. Stark, P. & Dews, P.B. (1980). Cannabinoids. II. Cardiovascular effects. J. Pharmacol. Exp. Ther., 214, 131-138.
37. Stein, E.A., Fuller, S.A., Edgemond, W.S. & Campbell, W.B. (1996). Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Br. J. Pharmacol., 119, 107-114.
38. Szabo, B., Hedler, L., Lichtwald, K. & Starke, K. (1987). ACTH increases noradrenaline release in pithed rabbits with electrically stimulated sympathetic outflow. Eur. J. Pharmacol., 136, 391-399.
39. Szabo, B. & Schultheiss, A. (1990). Desipramine inhibits sympathetic nerve activity in the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 469-476.
40. Szabo, B., Urban, R., Limberger, N. & Starke, K. (1995). Cardiovascular effects of agmatine, a 'clonidine-displacing substance', in conscious rabbits. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 268-273.
41. 2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 348, 593-600.
42. Urban, R. Szabo, B. & Starke, K. (1995). Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Eur. J. Pharmacol., 282, 29-37.
43. Varga, K., Lake, K.D., Huangfu, D., Guyenet, P.G. & Kunos, G. (1996). Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension, 28, 682-686.
44. 1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol., 278, 279-283.
45. 8-tetrahydrocannabinol-dimethylheptyl in rats. J. Cardiovasc. Pharmacol., 28, 332-336.
46. 9-trans-tetrahydrocannabinol. J. Pharm. Pharmacol., 26, 186-192.